View in EDS HTML Full Text PDF Full Text

Pretreatment serum level of interleukin-6 predicts carfilzomib-induced hypertension in relapsed/refractory multiple myeloma.

Saved in:

Bibliographic Details
Title:	Pretreatment serum level of interleukin-6 predicts carfilzomib-induced hypertension in relapsed/refractory multiple myeloma.
Authors:	Muramatsu, Ayako^1,2 (AUTHOR), Kobayashi, Tsutomu¹ (AUTHOR), Kawaji-Kanayama, Yuka^1,2 (AUTHOR), Uchiyama, Hitoji² (AUTHOR), Sasaki, Nana³ (AUTHOR), Uoshima, Nobuhiko³ (AUTHOR), Nakao, Mitsushige⁴ (AUTHOR), Takahashi, Ryoichi⁵ (AUTHOR), Shimura, Kazuho⁶ (AUTHOR), Kaneko, Hiroto⁶ (AUTHOR), Kiyota, Miki⁷ (AUTHOR), Wada, Katsuya⁷ (AUTHOR), Chinen, Yoshiaki^1,8 (AUTHOR), Hirakawa, Koichi⁸ (AUTHOR), Fuchida, Shin-ichi⁹ (AUTHOR), Shimazaki, Chihiro⁹ (AUTHOR), Mizutani, Shinsuke¹ (AUTHOR), Tsukamoto, Taku¹ (AUTHOR), Shimura, Yuji¹ (AUTHOR), Taniwaki, Masafumi^6,10 (AUTHOR)
Source:	Leukemia & Lymphoma. Jul2022, Vol. 63 Issue 7, p1678-1685. 8p.
Database:	Academic Search Ultimate
Full text is not displayed to guests. Login for full access.

Be the first to leave a comment!